Psychoactive Pharmaceutical Investigation
The Psychoactive Pharmaceutical Investigation Master’s program at the University of Wisconsin-Madison is a program that trains students to become leaders in the rapidly expanding field of psychoactive pharmaceutical research.
Provider
Details
Enrollment
Course Overview
The Psychoactive Pharmaceutical Investigation Master's program at the University of Wisconsin–Madison is an online program designed to train leaders in the field of psychoactive pharmaceutical research. The curriculum integrates chemistry and culture, equity and ethnobotany, and phenomenology and pharmacokinetics. Students gain mastery in unique pharmacologic and physiologic considerations for CNS drug development, laws, regulations, and ethical principles. The program also covers historical pressures and cutting-edge discoveries in psychedelic and cannabinoid research. The program confers a Master of Science in Pharmaceutical Sciences and requires 30 graduate credits. Completion time ranges from 12 months to three years depending on credit load per semester.
Who is this for?
Students interested in psychoactive pharmaceutical research, including those preparing for work in psychedelic and cannabinoid development, regulation, and related scientific fields.
About the Provider
The University of Wisconsin-Madison Transdisciplinary Center for Research in Psychoactive Substances is dedicated to exploring the scientific, historical, and cultural aspects of psychoactive substances, focusing on psychedelics.
View University of Wisconsin-Madison profileCourse Details
- Price$1,500
- FormatSelf-paced
- Lifecycle statusNo New Dates
- Skillspharmacologic considerationsphysiologic considerationsCNS drug developmentdrug delivery projectslaws and regulationsethical principleshistorical pressurescurrent challengescutting-edge discoveriespsychedelic researchcannabinoid researchregulatory frameworksPsychedelic and cannabinoid researchDrug delivery considerations
- Categories
Related Courses
View all courses10 Calls to Action: Toward an LGBTQ-Affirmative Psychedelic Therapy
By Chacruna
This article examines the history of psychedelic medicine being used in conversion therapy and the ongoing harms of heteronormative assumptions in psychedelic science. It outlines the need for LGBTQ-affirmative psychedelic therapy and identifies key areas for change in clinical practice and training.
8 Common Psychedelic Mistakes
By Psychedelics Today
Gain crucial insights into avoiding common pitfalls in psychedelic experiences with this 1-hour, self-paced webinar. Ideal for those seeking safe navigation.
ATMA Advanced Psychedelic-Assisted Therapy (PAT) Certification Program
By Atma Journey
This course is made for mental health professionals (in Canada) who want to learn how to work with psychedelics. The course staff includes Mark Haden Anthony Bossis, and many more.
Next cohort: Jun 1, 2026